QIAGEN NV Stock

Price

Target price

WKN: A2DKCH / Symbol: QGEN / Name: QIAGEN / Stock / Biotechnology & Medical Research / Mid Cap /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

QIAGEN NV Stock

QIAGEN NV is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.

As a result the target price of 47 € shows a slightly positive potential of 16.14% compared to the current price of 40.47 € for QIAGEN NV.

For the coming years our community has positive and negative things to say abot the QIAGEN NV stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Investment quota" there were negative voices in the community.

What does QIAGEN do?

Pros and Cons of QIAGEN NV in the next few years

Pros

S********** s********

G***** c******* t* c**********

M***** P*******

Cons

B****

C******** o* t** e**********

W********* I********* f** t** n*** y****

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of QIAGEN NV vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
QIAGEN NV
Uniqure B.V.
Novocure Ltd
Ironwood Pharmaceuticals

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2023-05-05

QIAGEN, a leading company in the Biotechnology & Medical Research industry, appears to exhibit a healthy financial performance based on the data provided. The company's assets, revenues, and net income have steadily increased over the past three years, which may indicate a solid financial foundation and growth potential.

Increasing Total Assets: QIAGEN's total assets grew from approximately $5.97 billion in 2020 to about $6.29 billion in 2022, representing a consistent year-over-year growth pattern. This indicates the company's ability to expand its business and maintain a strong asset base.

Rising Revenue: The total revenue generated by QIAGEN has shown an upward trend from $1.87 billion in 2020 to nearly $2.14 billion in 2022. Steady revenue growth is a positive sign for investors and suggests that the company is effectively managing its operations.

Feedback

Comments

Prediction Buy

Perf. (%) -

Target price 47.440

Change

Ends at

Qiagen (NYSE: QGEN) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $51.00 price target on the stock, up previously from $49.48.

Ratings data for QGEN provided by MarketBeat

Morgan Stanley

Prediction Buy

Perf. (%) -

Target price 48.240

Change

Ends at

Qiagen (NYSE: QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $52.00. They now have an "overweight" rating on the stock.

Ratings data for QGEN provided by MarketBeat